Search Results - "Assmann, Julian C"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
  2. 2
  3. 3

    The Immunometabolomic Interface Receptor Hydroxycarboxylic Acid Receptor 2 Mediates the Therapeutic Effects of Dimethyl Fumarate in Autoantibody-Induced Skin Inflammation by Wannick, Melanie, Assmann, Julian C, Vielhauer, Jakob F, Offermanns, Stefan, Zillikens, Detlef, Sadik, Christian D, Schwaninger, Markus

    Published in Frontiers in immunology (14-08-2018)
    “…The drug dimethyl fumarate (DMF) is in clinical use for the treatment of psoriasis and multiple sclerosis. In addition, it has recently been demonstrated to…”
    Get full text
    Journal Article
  4. 4

    Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE by Chen, Hui, Assmann, Julian C, Krenz, Antje, Rahman, Mahbubur, Grimm, Myriam, Karsten, Christian M, Köhl, Jörg, Offermanns, Stefan, Wettschureck, Nina, Schwaninger, Markus

    Published in The Journal of clinical investigation (01-05-2014)
    “…Taken orally, the drug dimethyl fumarate (DMF) has been shown to improve functional outcomes for patients with MS; however, it is unclear how DMF mediates a…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Genetic manipulation of brain endothelial cells in vivo by Assmann, Julian C., Körbelin, Jakob, Schwaninger, Markus

    Published in Biochimica et biophysica acta (01-03-2016)
    “…Brain endothelial cells take center stage of the blood–brain barrier. They maintain homeostasis in the central nervous system (CNS) and are involved in the…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE by Chen, Hui, Assmann, Julian C, Krenz, Antje, Rahman, Mahbubur, Grimm, Myriam, Karsten, Christian M, Kohl, Jorg, Offermanns, Stefan, Wettschureck, Nina, Schwaninger, Markus

    Published in The Journal of clinical investigation (01-05-2014)
    “…Taken orally, the drug dimethyl fumarate (DMF) has been shown to improve functional outcomes for patients with MS; however, it is unclear how DMF mediates a…”
    Get full text
    Journal Article
  12. 12

    Dimethyl Fumarate Ameliorates Disease Severity in a Mouse Model of Chronic Graft-Versus-Host Disease by Assmann, Julian C., Warrick, Kathrynne, Johns, Christopher, Farthing, Don E., Gress, Ronald E., Buxbaum, Nataliya P.

    “…Chronic graft-versus host disease (cGvHD) is a major complication of allogeneic hematopoietic stem cell transplantation. Standard treatment mainly consists of…”
    Get full text
    Journal Article